<?xml version="1.0" encoding="UTF-8"?>
<ref id="cas13513-bib-0015">
 <label>15</label>
 <mixed-citation publication-type="journal" id="cas13513-cit-0015">
  <string-name>
   <surname>Olsen</surname>
   <given-names>E</given-names>
  </string-name>, 
  <string-name>
   <surname>Duvic</surname>
   <given-names>M</given-names>
  </string-name>, 
  <string-name>
   <surname>Frankel</surname>
   <given-names>A</given-names>
  </string-name>, et al. 
  <article-title>Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T‐cell lymphoma</article-title>. 
  <source>J Clin Oncol</source>. 
  <year>2001</year>;
  <volume>19</volume>:
  <fpage>376</fpage>‐
  <lpage>388</lpage>.
  <pub-id pub-id-type="pmid">11208829</pub-id>
 </mixed-citation>
</ref>
